Rolipram, a stereospecific inhibitor of calmodulin-independent phosphodiesterase, causesβ-adrenoceptor subsensitivity in rat cerebral cortex

[1]  J. Schultz,et al.  Effects of lithium and antidepressants on electrophysiological and biochemical processes in the CNS. , 2009, Acta pharmacologica et toxicologica.

[2]  W. Löscher,et al.  Comparison of the anticonvulsant effects of two novel GABA uptake inhibitors and diazepam in amygdaloid kindled rats , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  J. Schultz,et al.  Chronic thyroxine treatment of rats down-regulates the noradrenergic cyclic AMP generating system in cerebral cortex. , 1985, The Journal of pharmacology and experimental therapeutics.

[4]  H. Schneider.  Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation. , 1984, Biochemical pharmacology.

[5]  R. Kincaid,et al.  Purification and properties of calmodulin-stimulated phosphodiesterase from mammalian brain. , 1984, The Journal of biological chemistry.

[6]  C. Davis,et al.  Assessment of selective inhibition of rat cerebral cortical calcium-independent and calcium-dependent phosphodiesterases in crude extracts using deoxycyclic AMP and potassium ions. , 1984, Biochimica et biophysica acta.

[7]  J. Schultz,et al.  Effects of long-term treatment of rats with antidepressants on adrenergic-receptor sensitivity in cerebral cortex: Structure activity study , 1983, Neurochemistry International.

[8]  H. Wachtel.  Neurotropic effects of the optical isomers of the selective adenosine cyclic 3′,5′‐monophosphate phosphodiesterase inhibitor rolipram in rats in‐vivo , 1983, The Journal of pharmacy and pharmacology.

[9]  H. Wachtel,et al.  Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors , 1983, Neuropharmacology.

[10]  A. Lewandowska,et al.  The Influence of Rolipram on the Central Serotoninergic System , 1981, Pharmacopsychiatria.

[11]  A. Janowsky,et al.  Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: Subsensitivity without reduction in β-adrenergic receptor binding , 1980, Neuropharmacology.

[12]  M. Roberts,et al.  Potentiation of responses of cortical neurones to 3,5-cyclic adenosine monophosphate by desipramine , 1979, Neuropharmacology.

[13]  A. Friedhoff,et al.  Intact presynaptic terminals required for beta‐adrenergic receptor regulation by desipramine , 1979, Journal of neurochemistry.

[14]  M. Roberts,et al.  POTENTIATION OF RESPONSES TO MONOAMINES BY ANTIDEPRESSANTS AFTER DESTRUCTION OF MONOAMINE AFFERENTS , 1979, British journal of pharmacology.

[15]  J. Vetulani,et al.  Mode of action of antidepressant drugs. , 1978, Biochemical pharmacology.

[16]  P. Molinoff,et al.  Effects of 6-hydroxydopamine on the development of the beta adrenergic receptor/adenylate cyclase system in rat cerebral cortex. , 1977, The Journal of pharmacology and experimental therapeutics.

[17]  J. Daly,et al.  4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. , 1976, Molecular pharmacology.

[18]  R. Stawarz,et al.  ADAPTIVE MECHANISMS OF THE NORADRENERGIC CYCLIC AMP GENERATING SYSTEM IN THE LIMBIC FOREBRAIN OF THE RAT: ADAPTATION TO PERSISTENT CHANGES IN THE AVAILABILITY OF NOREPINEPHRINE (NE) 1, 2 , 1976, Journal of neurochemistry.

[19]  S. Snyder,et al.  Beta adrenergic receptor binding in membrane preparations from mammalian brain. , 1976, Molecular pharmacology.

[20]  James N. Davis,et al.  Direct identification and characterisation of β-adrenergic receptors in rat brain , 1975, Nature.

[21]  C. Bradshaw,et al.  EFFECTS OF IPRINDOLE ON RESPONSES OF SINGLE CORTICAL AND CAUDATE NEURONES TO MONOAMINES AND ACETYLCHOLINE , 1975, British journal of pharmacology.

[22]  C. Bradshaw,et al.  EFFECTS OF DESIPRAMINE ON NEURONAL RESPONSES TO DOPAMINE, NORADRENALINE, 5‐HYDROXYTRYPTAMINE AND ACETYLCHOLINE IN THE CAUDATE NUCLEUS OF THE RAT , 1975, British journal of pharmacology.

[23]  C. Bradshaw,et al.  EFFECTS OF IMIPRAMINE AND DESIPRAMINE ON RESPONSES OF SINGLE CORTICAL NEURONES TO NORADRENALINE AND 5‐HYDROXYTRYPTAMINE , 1974, British journal of pharmacology.

[24]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.

[25]  S. Kakiuchi,et al.  Mechanism of stimulation of Ca2+ plus Mg2+ -dependent phospodiesterase from rat cerebral cortex by the modulator protein and Ca2+. , 1974, Biochemical and biophysical research communications.

[26]  U. Schwabe,et al.  Effect of psychotropic drugs on phosphodiesterase and cyclic AMP level in rat brain in vivo. , 1973, Brain research.

[27]  J. Daly,et al.  Accumulation of adenosine cyclic 3',5'-monophosphate in rat cerebral cortical slices. Stimulatory effect of alpha and beta adrenergic agents after treatment with 6-hydroxydopamine, 2,3,5-trihydroxyphenethylamine, and dihydroxytryptamines. , 1973, Molecular pharmacology.

[28]  J. Daly,et al.  ACCUMULATION OF CYCLIC ADENOSINE 3′, 5′‐MONOPHOSPHATE IN CEREBRAL CORTICAL SLICES FROM RAT AND MOUSE: STIMULATORY EFFECT OF α‐ AND β‐ADRENERGIC AGENTS AND ADENOSINE , 1973 .

[29]  J. Perkins,et al.  Effect of nerve degeneration by 6-hydroxydopamine on catecholamine-stimulated adenosine 3',5'-monophosphate formation in rat cerebral cortex. , 1973, Molecular pharmacology.

[30]  J. Daly,et al.  ADENOSINE 3′,5′‐MONOPHOSPHATE IN GUINEA PIG CEREBRAL CORTICAL SLICES: EFFECTS OF α‐ AND β‐ADRENERGIC AGENTS, HISTAMINE, SEROTONIN AND ADENOSINE , 1973 .

[31]  M. Moore,et al.  Characterization of the adrenergic receptors mediating a rise in cyclic 3'-5'-adenosine monophosphate in rat cerebral cortex. , 1973, The Journal of pharmacology and experimental therapeutics.

[32]  J. Daly,et al.  Cyclic adenosine 3',5'-monophosphate in guinea pig cerebral cortical slices. I. Formation of cyclic adenosine 3',5'-monophosphate from endogenous adenosine triphosphate and from radioactive adenosine triphosphate formed during a prior incubation with radioactive adenine. , 1973, The Journal of biological chemistry.

[33]  A. Gilman.  A protein binding assay for adenosine 3':5'-cyclic monophosphate. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Pöch.  Assay of phosphodiesterase with radioactively labeled cyclic 3′,5′-AMP as substrate , 2005, Naunyn-Schmiedebergs Archiv für Pharmakologie.

[35]  H. Wachtel.  Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors , 2004, Psychopharmacology.

[36]  R. Horowski,et al.  Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports , 1985 .

[37]  F. Bloom,et al.  Effects of prolonged treatment with lithium and tricyclic antidepressants on discharge frequency, norepinephrine responses and beta receptor binding in rat cerebellum: electrophysiological and biochemical comparison. , 1981, The Journal of pharmacology and experimental therapeutics.

[38]  J. Schultz,et al.  Adrenergic Subsensitivity of a Cell‐free Adenylate Cyclase from Rat Brain after Chronic Imipramine Treatment , 1980, Archiv der Pharmazie.

[39]  J. Daly,et al.  Acummulation of cyclic adenosine 3', 5'-monophosphate in cerebral cortical slices from rat and mouse: stimulatory effect of alpha- and beta-adrenergic agents and adenosine. , 1973, Journal of neurochemistry.

[40]  H. Sheppard,et al.  Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase. , 1971, Molecular pharmacology.